Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Investigation of the Drug Dimethoxbenzylidene Anabaseine in Treating Schizophrenia Patients

This study has been completed.
National Institute of Mental Health (NIMH)
Information provided by (Responsible Party):
University of Colorado, Denver Identifier:
First received: November 16, 2005
Last updated: June 30, 2015
Last verified: June 2015
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: October 2005
  Primary Completion Date: October 2005 (Final data collection date for primary outcome measure)